Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer

Fig. 4

Mutations with high allele frequency discovered in liquid biopsy. A Visualization of three TP53 mutations with high allele frequency using a genome browser. B Barplot showing the association between the highest allele frequency of mutations detected in each patient with their tumor metastasis status. Red bars represent patients with distant metastases, whereas blue bars represent patients without distant metastases. The y axis was in log10 scale

Back to article page